Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The Government of Canada will invest about $990,000 to enable Natrix Separations to develop and bring to market products to be used in the development and manufacturing of biopharmaceuticals and vaccines.
Subscribe to our email newsletter
Canada’s Labour Minister Lisa Raitt said the Canadian Government is investing in the people, businesses and communities of southern Ontario to create jobs, growth and long-term prosperity.
"Through the Investing in Business Innovation initiative, we are helping companies like Natrix Separations develop new ideas and take their innovations to market, so people in southern Ontario and around the world can benefit," Raitt added.
The fund, which is being granted through Federal Economic Development Agency for Southern Ontario’s ( FedDev Ontario) Investing in Business Innovation initiative will allow Natrix to leverage more than $4m in additional private sector investments from Canadian and International venture capital investors.
The funding will allow Natrix to design a prototype and develop single-use membrane-based chromatography products for large-scale biopharmaceutical manufacturing.
Natrix Separations produces chromatographic products for purification processes using a patented technology.
Natrix president and CEO John Chickosky said, ”This investment will play a critical role in accelerating the commercialization of these products."
Created in 2009, FedDev Ontario helps the southern Ontario economy by capitalizing on the region’s strengths and creating opportunities for jobs and economic growth.